Finzati - Logo
OTLK logo

Outlook Therapeutics, Inc.

OTLKBiotechnology
$0.67
+0.02 (+2.70%)
Current price
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$141.44M
Growth
-22.7%
Cash Flow
0/5
Trend
Negative
Evidence
Weak liquidity · 0.38Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 16, 2026, 12:09 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$0.67
Change2.70%
Market Cap$141.44M
52W Range0.16 - 3.39
Beta0.80
Gross Margin46.49%
Oper. Margin-47.44%
Profit Margin-44.16%
Debt/Eq-0.94
Current Ratio0.38
Quick Ratio0.31
Revenue 5Y-22.73%

Investment DNA

How strong this company looks for long-term investors

27
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
20/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
20/100
Why this score
Weak liquidity · 0.38Weak profitability

Analyst view

Analyst sentiment and price target

Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-08-16
Low
$1.60
Mean
$2.80
Median
$2.80
High
$4.00

Company Overview

IPO: 6/14/2016
Industry: Biotechnology
P/B i: -1.15
Debt / Equity i: -0.94
Operating Margin: -4744.25%
Net Margin: -4416.22%
ROE i: -
ROIC: -

Financial Health

Score4 / 20
Debt / Equity: -0.94
Current Ratio: 0.38
Quick Ratio: 0.31
Status: HighRisk

Warnings

  • Weak Liquidity
  • Weak quick ratio

Insider Transactions

Recent executive and insider activity

1 high-volume insider sell detected
KENYON LAWRENCE A
Transaction: 08/14/2026
BUY
Change
+101,010
Price
$1.10
Filing
08/14/2026
Type
BUY
KENYON LAWRENCE A
Transaction: 08/14/2026
BUY
Change
+101,010
Price
$0.99
Filing
08/14/2026
Type
BUY
Jahr Robert Charles
Transaction: 08/14/2026
BUY
Change
+151,515
Price
$1.10
Filing
08/14/2026
Type
BUY